Source: Nasdaq

Pacira: Pacira BioSciences Announces Repurchase Authorization

(RTTNews) - Pacira BioSciences (PCRX) said its Board of Directors has authorized a share repurchase program of up to an aggregate of $300 million with respect to the common stock, replacing the prior authorization. The share repurchase authorization expires at the end of December

Read full article »
Annual Revenue
$500M-1.0B
Employees
500-1.0K
Frank D. Lee's photo - CEO of Pacira

CEO

Frank D. Lee

CEO Approval Rating

97/100

Read more